FDA announces plans to pilot end-stage kidney disease technology in new program
Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA s Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.